Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015–2020
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Fomepizole inhibits formation of toxic acetaminophen (APAP) metabolites and may prevent or reverse mitochondrial toxicity. Given these mechanisms, it may be beneficial in patients with severe APAP toxicity. Current patterns of use for this indication are not well-studied. METHODS: This is a secondary analysis of patients enrolled in the Toxicology Investigators Consortium (ToxIC) database from January 2015 to July 2020. We queried cases in which APAP was listed as an ingested agent and fomepizole was also administered. We excluded cases in which APAP was not the primary agent, N-acetylcysteine (NAC) was not administered, or fomepizole was explicitly administered for another indication. Additionally, we sent a survey to each ToxIC site that administered fomepizole for APAP toxicity to better understand when, why, and how they were using it for this indication. RESULTS: Twenty-five cases of fomepizole administration following an APAP ingestion met our inclusion criteria. There were one to four cases per year between 2015 and 2019 and eight cases in 2020. Seventeen of 25 (68%) cases were for a known acute ingestion. Eighteen of 25 (72%) patients developed hepatotoxicity (AST or ALT > 1000 IU/L) and 10 of 25 (40%) developed coagulopathy (PT > 15s). This was an ill patient population, with 18 of 25 (72%) developing metabolic acidosis (pH <7.20), 12 of 25 (48%) were intubated, 9 of 25 (36%) receiving vasopressors, and 6 of 25 (24%) receiving continuous renal replacement therapy. Overall, mortality was 24%. CONCLUSION: The use of fomepizole is increasing in frequency in a small subset of critically ill and acutely APAP-poisoned patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The evidence for use of fomepizole in this context is primarily from animal models [113] and small case series [114,115].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [115]
Citations
Cites
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667
Gummin, D. D., Mowry, J. B., Beuhler, M. C., Spyker, D. A., Brooks, D. E., Dibert, K. W., Rivers, L. J., Pham, N. P. T., & Ryan, M. L. (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1834219 · Cited by 401
A Review of Acetaminophen Poisoning
Hodgman, M. J., & Garrard, A. R. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.07.006 · Cited by 314
Fomepizole for Ethylene Glycol and Methanol Poisoning
Brent, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0806112 · Cited by 240
Bailey, B., Amre, D. K., & Gaudreault, P. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00048 · Cited by 196
Reduction of Toxic Metabolite Formation of Acetaminophen
Hazai, E., Vereczkey, L., & Monostory, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6541 · Cited by 169
Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup
Gosselin, S., Juurlink, D. N., Kielstein, J. T., Ghannoum, M., Lavergne, V., Nolin, T. D., Hoffman, R. S., & workgroup, O. B. O. T. E. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.946994 · Cited by 129
Akakpo, J., Ramachandran, A., Kandel, S., Ni, H., Kumer, S., Rumack, B., & Jaeschke, H. (2018) · Human & Experimental Toxicology · doi:10.1177/0960327118774902 · Cited by 111
Chiew, A. L., Isbister, G. K., Kirby, K. A., Page, C. B., Chan, B. S. H., & Buckley, N. A. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1334915 · Cited by 107
Research works printed but not linked: 2
- Kiernan EA, 2019, Case Rep Emerg Med, 2019, 9301432
- Link SL, 2021, Clin Toxicol, 28, 1
Cited by
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
“The evidence for use of fomepizole in this context is primarily from animal models [113] and small case series [114,115].”
Background
Metadata
- Authors
- Filip, A. B., Berg, S. E., Mullins, M. E., Schwarz, E. S., & On behalf of the Toxicology Investigators Consortium (ToxIC)
- Affiliations
- Washington University in St. Louis (US)
- University of Illinois Chicago (US)
- Corresponding author
- Filip, Ari B.
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2022-05-05
- Volume
- 60
- Issue
- 9
- Pages
- 1006-1011
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W4229045869
- Cited by
- 13
- References
- 33
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 4 · 2022: 2
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
- Keywords
- fomepizole, acetaminophen toxicity, adjunctive therapy, hepatotoxicity, coagulopathy, metabolic acidosis, N-acetylcysteine, mitochondrial toxicity, critically ill patients, mortality
- MeSH terms
- Fomepizole, Acetaminophen, Acetylcysteine, Humans, Databases, Factual, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015–2020. https://app.cochat.ai/papers/10.1080/15563650.2022.2070071
- The paper
- Filip, A. B., Berg, S. E., Mullins, M. E., Schwarz, E. S., & On behalf of the Toxicology Investigators Consortium (ToxIC). (2022). Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015–2020. Clinical Toxicology. https://doi.org/10.1080/15563650.2022.2070071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.